[spacer image]
BD
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]

Did you know?
[spacer image] BD manufactured the first syringe made specifically for insulin injection. Learn more about BD's history » [spacer image]
[spacer image]

About Us
Email Page Print
[spacer image]

BD Ventures, L.L.C., a wholly-owned subsidiary of Becton Dickinson and Company (BD), was founded in 1999. BD Ventures is a strategic investor, and hence seeks to invest in venture-stage companies that fit well with BD's business segments: BD Medical, BD Diagnostics, and BD Biosciences. BD Ventures has led rounds or co-invested alongside private and corporate venture capital funds.


Mission

BD Ventures' mission is to invest in emerging medical technology, life science and diagnostics companies offering new technology platforms and products with the potential to enhance BD's core strategy of growth through innovation. BD Ventures aims for exposure to companies of strategic interest to BD's as well as superior return on investment.

BD Ventures is strategically aligned with its internal customers, including its worldwide business segments and the Executive Committee. It is also a valued collaborator to its external customers, including the entrepreneurs, their companies and the venture capital community, with whom it partners.


We Bring Experience and Commitment

Our staff represents a wide range of backgrounds across the life sciences, with extensive experience in general management, business development, research and development, and finance.


Access to Resources

Beyond capital, BD Ventures provides unique access to valuable scientific and commercial resources and insight into the emerging needs of the healthcare industry segments industries in which we operate.

[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]